PT  - JOURNAL ARTICLE
ED  - ,
TI  - Review of Biosafety Guidelines
DP  - 1989 Nov 01
TA  - PDA Journal of Pharmaceutical Science and Technology
PG  - 252--258
VI  - 43
IP  - 6
4099  - http://journal.pda.org/content/43/6/252.short
4100  - http://journal.pda.org/content/43/6/252.full
SO  - PDA J Pharm Sci Technol1989 Nov 01; 43
AB  - The increased use of recombinant DNA technology, human cell lines, and other human-source materials in the production of pharmaceutical products, has brought to the fore concern for the protection of our employees. A number of guidelines are available that cover “biosafety” issues and are reviewed in this article.